[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Superficial Bladder Cancer Drugs Sales Market Report Forecast 2017-2021

April 2017 | 122 pages | ID: G8236F282CCEN
S&P Consulting

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Altor BioScience Corporation
APIM Therapeutics AS
Bavarian Nordic A/S
Cold Genesys, Inc.
Spectrum Pharmaceuticals, Inc.
Telesta Therapeutics Inc.
UroGen Pharmaceuticals, Ltd.
Viventia Bio Inc.
endo pharmaceutical

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
    It provides distinctive graphics and exemplified analysis of major market segments
1 SUPERFICIAL BLADDER CANCER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Superficial Bladder Cancer Drugs
1.2 Classification of Superficial Bladder Cancer Drugs
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Superficial Bladder Cancer Drugs
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Superficial Bladder Cancer Drugs Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Superficial Bladder Cancer Drugs (2012-2021)
  1.5.1 Global Superficial Bladder Cancer Drugs Sales and Growth Rate (2012-2021)
  1.5.2 Global Superficial Bladder Cancer Drugs Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON SUPERFICIAL BLADDER CANCER DRUGS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 SUPERFICIAL BLADDER CANCER DRUGS MANUFACTURING COST ANALYSIS

3.1 Superficial Bladder Cancer Drugs Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Superficial Bladder Cancer Drugs

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Superficial Bladder Cancer Drugs Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Superficial Bladder Cancer Drugs Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL SUPERFICIAL BLADDER CANCER DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Superficial Bladder Cancer Drugs Market Competition by Manufacturers
  5.1.1 Global Superficial Bladder Cancer Drugs Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Superficial Bladder Cancer Drugs Revenue and Share by Manufacturers (2012-2017)
5.2 Global Superficial Bladder Cancer Drugs (Volume and Value) by Type
  5.5.1 Global Superficial Bladder Cancer Drugs Sales and Market Share by Type (2012-2017)
  5.5.2 Global Superficial Bladder Cancer Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Superficial Bladder Cancer Drugs (Volume and Value) by Regions
  5.3.1 Global Superficial Bladder Cancer Drugs Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Superficial Bladder Cancer Drugs Revenue and Market Share by Regions (2012-2017)
5.4 Global Superficial Bladder Cancer Drugs (Volume) by Application

6 UNITED STATES SUPERFICIAL BLADDER CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 United States Superficial Bladder Cancer Drugs Sales and Value (2012-2017)
  6.1.1 United States Superficial Bladder Cancer Drugs Sales and Growth Rate (2012-2017)
  6.1.2 United States Superficial Bladder Cancer Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 United States Superficial Bladder Cancer Drugs Sales Price Trend (2012-2017)
6.2 United States Superficial Bladder Cancer Drugs Sales and Market Share by Manufacturers
6.3 United States Superficial Bladder Cancer Drugs Sales and Market Share by Type
6.4 United States Superficial Bladder Cancer Drugs Sales and Market Share by Application

7 CHINA SUPERFICIAL BLADDER CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 China Superficial Bladder Cancer Drugs Sales and Value (2012-2017)
  7.1.1 China Superficial Bladder Cancer Drugs Sales and Growth Rate (2012-2017)
  7.1.2 China Superficial Bladder Cancer Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 China Superficial Bladder Cancer Drugs Sales Price Trend (2012-2017)
7.2 China Superficial Bladder Cancer Drugs Sales and Market Share by Manufacturers
7.3 China Superficial Bladder Cancer Drugs Sales and Market Share by Type
7.4 China Superficial Bladder Cancer Drugs Sales and Market Share by Application

8 EUROPE SUPERFICIAL BLADDER CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Superficial Bladder Cancer Drugs Sales and Value (2012-2017)
  8.1.1 Europe Superficial Bladder Cancer Drugs Sales and Growth Rate (2012-2017)
  8.1.2 Europe Superficial Bladder Cancer Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Superficial Bladder Cancer Drugs Sales Price Trend (2012-2017)
8.2 Europe Superficial Bladder Cancer Drugs Sales and Market Share by Manufacturers
8.3 Europe Superficial Bladder Cancer Drugs Sales and Market Share by Type
8.4 Europe Superficial Bladder Cancer Drugs Sales and Market Share by Application

9 JAPAN SUPERFICIAL BLADDER CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Superficial Bladder Cancer Drugs Sales and Value (2012-2017)
  9.1.1 Japan Superficial Bladder Cancer Drugs Sales and Growth Rate (2012-2017)
  9.1.2 Japan Superficial Bladder Cancer Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Superficial Bladder Cancer Drugs Sales Price Trend (2012-2017)
9.2 Japan Superficial Bladder Cancer Drugs Sales and Market Share by Manufacturers
9.3 Japan Superficial Bladder Cancer Drugs Sales and Market Share by Type
9.4 Japan Superficial Bladder Cancer Drugs Sales and Market Share by Application

10 GLOBAL SUPERFICIAL BLADDER CANCER DRUGS MANUFACTURERS ANALYSIS

10.1 Altor BioScience Corporation
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 APIM Therapeutics AS
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Bavarian Nordic A/S
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Cold Genesys, Inc.
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Spectrum Pharmaceuticals, Inc.
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Telesta Therapeutics Inc.
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 UroGen Pharmaceuticals, Ltd.
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Viventia Bio Inc.
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 endo pharmaceutical
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL SUPERFICIAL BLADDER CANCER DRUGS MARKET FORECAST (2017-2021)

13.1 Global Superficial Bladder Cancer Drugs Sales, Revenue Forecast (2017-2021)
13.2 Global Superficial Bladder Cancer Drugs Sales Forecast by Regions (2017-2021)
13.3 Global Superficial Bladder Cancer Drugs Sales Forecast by Type (2017-2021)
13.4 Global Superficial Bladder Cancer Drugs Sales Forecast by Application (2017-2021)

14 APPENDIX


LIST OF TABLES AND FIGURES

Figure Picture of Superficial Bladder Cancer Drugs
Table Classification of Superficial Bladder Cancer Drugs
Figure Global Sales Market Share of Superficial Bladder Cancer Drugs by Type in 2015
Table Applications of Superficial Bladder Cancer Drugs
Figure Global Sales Market Share of Superficial Bladder Cancer Drugs by Application in 2015
Figure United States Superficial Bladder Cancer Drugs Revenue and Growth Rate (2012-2021)
Figure China Superficial Bladder Cancer Drugs Revenue and Growth Rate (2012-2021)
Figure Europe Superficial Bladder Cancer Drugs Revenue and Growth Rate (2012-2021)
Figure Japan Superficial Bladder Cancer Drugs Revenue and Growth Rate (2012-2021)
Figure Global Superficial Bladder Cancer Drugs Sales and Growth Rate (2012-2021)
Figure Global Superficial Bladder Cancer Drugs Revenue and Growth Rate (2012-2021)
Table Global Superficial Bladder Cancer Drugs Sales of Key Manufacturers (2012-2017)
Table Global Superficial Bladder Cancer Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Superficial Bladder Cancer Drugs Sales Share by Manufacturers
Figure 2016 Superficial Bladder Cancer Drugs Sales Share by Manufacturers
Table Global Superficial Bladder Cancer Drugs Revenue by Manufacturers (2012-2017)
Table Global Superficial Bladder Cancer Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Superficial Bladder Cancer Drugs Revenue Share by Manufacturers
Table 2016 Global Superficial Bladder Cancer Drugs Revenue Share by Manufacturers
Table Global Superficial Bladder Cancer Drugs Sales and Market Share by Type (2012-2017)
Table Global Superficial Bladder Cancer Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Superficial Bladder Cancer Drugs by Type (2012-2017)
Figure Global Superficial Bladder Cancer Drugs Sales Growth Rate by Type (2012-2017)
Table Global Superficial Bladder Cancer Drugs Revenue and Market Share by Type (2012-2017)
Table Global Superficial Bladder Cancer Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Superficial Bladder Cancer Drugs by Type (2012-2017)
Figure Global Superficial Bladder Cancer Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Superficial Bladder Cancer Drugs Sales and Market Share by Regions (2012-2017)
Table Global Superficial Bladder Cancer Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Superficial Bladder Cancer Drugs by Regions (2012-2017)
Figure Global Superficial Bladder Cancer Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Superficial Bladder Cancer Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Superficial Bladder Cancer Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Superficial Bladder Cancer Drugs by Regions (2012-2017)
Figure Global Superficial Bladder Cancer Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Superficial Bladder Cancer Drugs Sales and Market Share by Application (2012-2017)
Table Global Superficial Bladder Cancer Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Superficial Bladder Cancer Drugs by Application (2012-2017)
Figure Global Superficial Bladder Cancer Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Superficial Bladder Cancer Drugs Sales and Growth Rate (2012-2017)
Figure United States Superficial Bladder Cancer Drugs Revenue and Growth Rate (2012-2017)
Figure United States Superficial Bladder Cancer Drugs Sales Price Trend (2012-2017)
Table United States Superficial Bladder Cancer Drugs Sales by Manufacturers (2012-2017)
Table United States Superficial Bladder Cancer Drugs Market Share by Manufacturers (2012-2017)
Table United States Superficial Bladder Cancer Drugs Sales by Type (2012-2017)
Table United States Superficial Bladder Cancer Drugs Market Share by Type (2012-2017)
Table United States Superficial Bladder Cancer Drugs Sales by Application (2012-2017)
Table United States Superficial Bladder Cancer Drugs Market Share by Application (2012-2017)
Figure China Superficial Bladder Cancer Drugs Sales and Growth Rate (2012-2017)
Figure China Superficial Bladder Cancer Drugs Revenue and Growth Rate (2012-2017)
Figure China Superficial Bladder Cancer Drugs Sales Price Trend (2012-2017)
Table China Superficial Bladder Cancer Drugs Sales by Manufacturers (2012-2017)
Table China Superficial Bladder Cancer Drugs Market Share by Manufacturers (2012-2017)
Table China Superficial Bladder Cancer Drugs Sales by Type (2012-2017)
Table China Superficial Bladder Cancer Drugs Market Share by Type (2012-2017)
Table China Superficial Bladder Cancer Drugs Sales by Application (2012-2017)
Table China Superficial Bladder Cancer Drugs Market Share by Application (2012-2017)
Figure Europe Superficial Bladder Cancer Drugs Sales and Growth Rate (2012-2017)
Figure Europe Superficial Bladder Cancer Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Superficial Bladder Cancer Drugs Sales Price Trend (2012-2017)
Table Europe Superficial Bladder Cancer Drugs Sales by Manufacturers (2012-2017)
Table Europe Superficial Bladder Cancer Drugs Market Share by Manufacturers (2012-2017)
Table Europe Superficial Bladder Cancer Drugs Sales by Type (2012-2017)
Table Europe Superficial Bladder Cancer Drugs Market Share by Type (2012-2017)
Table Europe Superficial Bladder Cancer Drugs Sales by Application (2012-2017)
Table Europe Superficial Bladder Cancer Drugs Market Share by Application (2012-2017)
Figure Japan Superficial Bladder Cancer Drugs Sales and Growth Rate (2012-2017)
Figure Japan Superficial Bladder Cancer Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Superficial Bladder Cancer Drugs Sales Price Trend (2012-2017)
Table Japan Superficial Bladder Cancer Drugs Sales by Manufacturers (2012-2017)
Table Japan Superficial Bladder Cancer Drugs Market Share by Manufacturers (2012-2017)
Table Japan Superficial Bladder Cancer Drugs Sales by Type (2012-2017)
Table Japan Superficial Bladder Cancer Drugs Market Share by Type (2012-2017)
Table Japan Superficial Bladder Cancer Drugs Sales by Application (2012-2017)
Table Japan Superficial Bladder Cancer Drugs Market Share by Application (2012-2017)
Table Altor BioScience Corporation Basic Information List
Table Altor BioScience Corporation Superficial Bladder Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Altor BioScience Corporation Superficial Bladder Cancer Drugs Global Market Share (2012-2017)
Table APIM Therapeutics AS Basic Information List
Table APIM Therapeutics AS Superficial Bladder Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure APIM Therapeutics AS Superficial Bladder Cancer Drugs Global Market Share (2012-2017)
Table Bavarian Nordic A/S Basic Information List
Table Bavarian Nordic A/S Superficial Bladder Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bavarian Nordic A/S Superficial Bladder Cancer Drugs Global Market Share (2012-2017)
Table Cold Genesys, Inc. Basic Information List
Table Cold Genesys, Inc. Superficial Bladder Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Cold Genesys, Inc. Superficial Bladder Cancer Drugs Global Market Share (2012-2017)
Table Spectrum Pharmaceuticals, Inc. Basic Information List
Table Spectrum Pharmaceuticals, Inc. Superficial Bladder Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Spectrum Pharmaceuticals, Inc. Superficial Bladder Cancer Drugs Global Market Share (2012-2017)
Table Telesta Therapeutics Inc. Basic Information List
Table Telesta Therapeutics Inc. Superficial Bladder Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Telesta Therapeutics Inc. Superficial Bladder Cancer Drugs Global Market Share (2012-2017)
Table UroGen Pharmaceuticals, Ltd. Basic Information List
Table UroGen Pharmaceuticals, Ltd. Superficial Bladder Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure UroGen Pharmaceuticals, Ltd. Superficial Bladder Cancer Drugs Global Market Share (2012-2017)
Table Viventia Bio Inc. Basic Information List
Table Viventia Bio Inc. Superficial Bladder Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Viventia Bio Inc. Superficial Bladder Cancer Drugs Global Market Share (2012-2017)
Table endo pharmaceutical Basic Information List
Table endo pharmaceutical Superficial Bladder Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure endo pharmaceutical Superficial Bladder Cancer Drugs Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Superficial Bladder Cancer Drugs
Figure Manufacturing Process Analysis of Superficial Bladder Cancer Drugs
Figure Superficial Bladder Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Superficial Bladder Cancer Drugs Major Manufacturers in 2015
Table Major Buyers of Superficial Bladder Cancer Drugs
Table Distributors/Traders List
Figure Global Superficial Bladder Cancer Drugs Sales and Growth Rate Forecast (2017-2021)
Figure Global Superficial Bladder Cancer Drugs Revenue and Growth Rate Forecast (2017-2021)
Table Global Superficial Bladder Cancer Drugs Sales Forecast by Regions (2017-2021)
Table Global Superficial Bladder Cancer Drugs Sales Forecast by Type (2017-2021)
Table Global Superficial Bladder Cancer Drugs Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Altor BioScience Corporation
APIM Therapeutics AS
Bavarian Nordic A/S
Cold Genesys, Inc.
Spectrum Pharmaceuticals, Inc.
Telesta Therapeutics Inc.
UroGen Pharmaceuticals, Ltd.
Viventia Bio Inc.
endo pharmaceutical
SANOFI


More Publications